Aspire-Lakewood Holdings, Inc.

ASBPW ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Operating Activities
Net Income $-1.3M $-3.2M $-4.7M $-1.9M $-2.0M $-15.9M $-765.7K $-216.3K
Depreciation & Amortization — — — — — — — —
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $144.1K $13.4K $0 $0 $0 $14.1M — —
Net Cash from Operating Activities $-2.1M $-3.0M $-927.8K $-1.1M $-1.1M $-1.8M $479.6K $-495.5K
Investing Activities
Capital Expenditures — — — — — — — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities — — — — — — — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $8.4M $7.9M $-16.5K $2.8M $0 $3.1M $-492.5K $492.5K
Net Change in Cash $6.3M $4.9M $-944.4K $1.7M $-1.1M $1.3M $-12.9K $-3.1K
Free Cash Flow — — — — — — — —
← Newer Page 1 of 3 Older →